Financial risk, hospital cost, complications and comorbidities (CCc) in non-CC stratified urology diagnostic related groups.
The federal Medicare Diagnosis Related Group payment mechanism is undergoing constant change. Significant interest has been generated at the health policy level regarding reimbursement for patients with complications and comorbidities. The purpose of this study was to analyze hospital resource consumption for patients in the seventeen urology non-complicating condition (CC) stratified Diagnostic Related Groups (DRGs), currently 45 percent of urology DRGs. We analyzed 185 Medicare patients in these non-CC stratified urology DRGs and found that patients with more CCs per patient had higher total hospital costs per patient, financial risk under DRGs, a greater percentage of outliers, and a higher mortality, than patients in these same DRGs with fewer CCs per patient. These findings suggest that the current DRG system is inequitable to some patients and certain hospitals vis-a-vis non-CC stratified urology DRGs. The Health Care Financing Administration has not significantly changed the complicating condition urology DRG classification, as of its recent May, 1988 legislation. Financial disincentives to treat these patients may affect both their access and quality of care in the future.
D014487:Centers for Medicare and Medicaid Services, U.S.; D003365:Costs and Cost Analysis; D003953:Diagnosis-Related Groups / Q000191:economics*; D004194:Disease / Q000150:complications; D006746:Hospital Bed Capacity, 500 and over; D006748:Hospital Departments / Q000191:economics*; D006801:Humans; D006278:Medicare / Q000191:economics*; D009017:Morbidity; D009519:New York City; D011444:Prospective Payment Assessment Commission; D011445:Prospective Payment System; D012307:Risk Factors; D014481:United States; D014573:Urology Department, Hospital / Q000191:economics*